New PBM Model Places Patients First, Delivers Effective Coordination of Care

President Trump Wants to Reduce Patient Out-of-Pocket Costs.

BeneCard PBF’s Expert Clinical Care Coordination Improves Patient Safety and Reduces Costs by Combatting Inappropriate Prescribing.

 The Trump administration’s blueprint for improvements to the American healthcare system calls out the need to reduce patient out-of-pocket costs. BeneCard PBF, a privately owned, independent PBM, helps keep costs down for patients and plan sponsors by providing expert clinical coordination of care focused on patient safety.

Each year, the United States spends nearly $1 billion on inappropriate and unnecessary prescribing that puts patients at risk. Adverse drug reactions, often caused by such practices, are a leading cause of hospitalization in the U.S. and can double a patient’s risk of mortality, as well as the length and cost of hospital stays. This, in turn, contributes to the rising cost of healthcare, including patients’ out-of-pocket expenses.

BeneCard PBF reduces these risks and their associated costs by improving the communication between patients, pharmacies and physicians. Founded on the principle of clinical excellence, the company provides clinical management of care that helps members lead healthier lives and reduces the number of inappropriate prescription claims.

Pharmacists at BeneCard PBF act as central liaisons between physicians, pharmacies, members, plan sponsors and specialists involved in patient care. In addition, the company’s advanced claim processing system ensures a high standard of communication by providing real-time, point-of-sale messaging. Working together, BeneCard PBF, pharmacies and healthcare providers can help patients get healthier, sooner and prevent contraindicated and potentially harmful medications from being placed in patients’ hands.

Although transparency and rebate structures have received a great deal of attention in the media and at all levels of government, these issues are symptoms of an industry that must evolve to put patient safety first. BeneCard PBF acts to prevent catastrophic medical complications caused by inappropriate drug utilization. While other PBMs answer to shareholders and Wall Street, BeneCard PBF’s status as an independent, privately owned organization allows it to align with patients’ best interests and plan sponsors’ goals.

BeneCard PBF embraces a patient-first approach that gives members the care they need, leading to fewer health complications and lower overall costs. Its prescription trend results prove the effectiveness of this approach. Although drug costs continue to rise and the PBM industry’s average seven-year prescription trend sits at 47.80%, BeneCard PBF’s seven-year trend is less than half that – just 19.67%. Lower prescription trends equate to savings that compound year after year. BeneCard PBF continually outperforms the industry thanks to its clinically focused, ethical and transparent approach.

BeneCard PBF is a national, full-service pharmacy benefit manager (PBM) that excels in patient-centric care. The company defies industry norms and delivers clinically focused, ethical and purely transparent PBM solutions. To achieve proven lower net costs, the company aligns its interests with its clients’ needs through proactive clinical programs and award-winning customer service. For more information, visit www.benecardpbf.com or contact Hugh Gallagher at 267-605-6428.

 

Benecard PBF Disrupts PBM Market By Offering Full Pass Through of Rebates

President Trump Proposes PBMs Pass Through at Least 33% of Rebates; BeneCard PBF’s Purely Transparent Model Offers 100% Pass-Through of All Drug Manufacturer Rebates

As national attention focuses more strongly on pharmacy benefit managers (PBMs) and drug costs, the presidential administration has proposed PBMs pass through at least 33% of all rebates collected on drugs covered by Medicare Part D. BeneCard PBF already offers full pass-through of the rebates it receives to its clients.

The call for rebate pass-through is based on concerns that PBMs retain undefined drug rebate amounts for themselves, adding to their profits rather than lowering prices for patients and plan sponsors. BeneCard PBF believes in a more transparent approach to rebates and pharmacy benefit management. The company offers full pass-through arrangements that help plan sponsors clearly see how prescription benefit dollars are being spent. Under BeneCard PBF’s transparent model, clients benefit from immediate impact from negotiated improvements in both drug discounts and rebates.

BeneCard PBF’s clinically focused model keeps patients at the forefront. Members get the right medication for them, not the medications that create profits for the PBM through rebate retention. The company’s experience has proven that a business model driven by patient-centric clinical coordination of care, not rebates, reduces costs.

The result of this focus clearly show in BeneCard PBF’s trend. Lower prescription trends equate to savings that compound year after year. Although drug costs continue to rise, and the PBM industry’s average seven-year prescription trend sits at 47.80%, BeneCard PBF’s seven-year trend is less than half that at 19.67%. Thanks to its clinically focused, ethical and transparent approach combined with adaptable, advanced technology, BeneCard PBF continually outperforms the industry.

BeneCard PBF is a national, full-service Prescription Benefit Manager that excels in patient-centric care. The company defies industry norms and delivers clinically focused, ethical and purely transparent PBM solutions. To achieve proven lower net costs, the company aligns its interests with its clients’ needs through proactive clinical programs and award-winning customer service. For more information, visit www.benecardpbf.com or contact Hugh Gallagher at 267-605-6428.

 

Innovative PBM Introduces Pharmacogenetics Offering

Benecard PBF Launches BenePrecise to Eliminate Trial and Error in Finding Medications That Work

BeneCard PBF, a leader in providing clinical solutions that address the crisis of rising drug costs, has taken a step toward more efficient, personalized clinical care for members through its BenePrecise Pharmacogenetics program. Pharmacogenetics allows prescribers and pharmacists to understand how medications react differently in the body based on an individual’s metabolism. BenePrecise applies the results of a fast and easy-to-administer pharmacogenetics test to enhance member safety, improve treatment outcomes and prevent wasteful drug spending.

BenePrecise utilizes precision medicine, which evaluates and considers a patient’s metabolism, environment and lifestyle, to develop effective, individualized treatment plans. Through BenePrecise, BeneCard PBF’s pharmacists work with members and their prescribers to coordinate changes in drug therapies, as indicated by pharmacogenetic testing. This ensures that members receive the most clinically appropriate and effective medications. By proactively identifying which drug therapies will not work, or are likely to cause severe adverse reactions, clients and their members can avoid unnecessary risks and expenses.

“We are excited to offer our BenePrecise program,” says Jennifer Fuhrmann, PharmD and Vice President of Clinical Services for BeneCard PBF. “Pharmacogenetic testing can have a measurable positive impact for members who live with chronic health challenges such as diabetes or high cholesterol. Our pharmacists can help them move quickly onto the most appropriate drug therapy and improve their health with fewer side effects and less risk, based on their unique metabolism.”

There are no doctor’s visits required to administer the test. Members can collect and submit the sample from home using a simple cheek swab. The markers identified by pharmacogenetic testing do not change over a member’s lifetime, so repeat tests are not required.

BenePrecise enables a personalized approach to care aimed at reducing costs, improving treatment efficacy and preventing adverse drug reactions.

About BeneCard PBF

Through pharmacogenetics and proactive clinical programs, BeneCard PBF enhances patient outcomes while lowering prescription drug costs. With offices in Florida, Pennsylvania and New Jersey, BeneCard PBF administers fixed-rate and self-funded prescription benefit programs. The company offers innovative solutions to control costs while providing the highest quality service available in prescription benefit management.